PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportsbone diseases
MeSH D001847 - bone diseases
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D009140:Musculoskeletal diseases
0 Companies
0 Drugs
Success rate
D001847: 
Bone diseases
$
Success rate
D000070603:Coxa magna
0 Companies
0 Drugs
Success rate
D001845:Bone cysts
0 Companies
0 Drugs
Success rate
D001848:Developmental bone diseases
0 Companies
0 Drugs
Success rate
D001849:Endocrine bone diseases
0 Companies
0 Drugs
Success rate
D001850:Infectious bone diseases
D001851:Metabolic bone diseases
0 Companies
0 Drugs
Success rate
D001859:Bone neoplasms
$
Success rate
D001862:Bone resorption
$
Success rate
D004803:Eosinophilic granuloma
0 Companies
0 Drugs
Success rate
D004839:Slipped epiphyses
0 Companies
0 Drugs
Success rate
D010000:Osteitis
0 Companies
0 Drugs
Success rate
D010001:Osteitis deformans
$
Success rate
D010004:Primary hypertrophic osteoarthropathy
0 Companies
0 Drugs
Success rate
D010005:Secondary hypertrophic osteoarthropathy
0 Companies
0 Drugs
Success rate
D010007:Osteochondritis
0 Companies
0 Drugs
Success rate
D010020:Osteonecrosis
0 Companies
0 Drugs
Success rate
D013122:Spinal diseases
0 Companies
0 Drugs
Success rate
D015576:Hyperostosis
0 Companies
0 Drugs
Success rate
D017760:Bone malalignment
0 Companies
0 Drugs
Success rate
D055034:Osteochondrosis
0 Companies
0 Drugs
Success rate
D056304:Genu valgum
0 Companies
0 Drugs
Success rate
D056305:Genu varum
0 Companies
0 Drugs
Success rate
D060906:Coxa valga
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
50%
3/6
Phase 2
63%
5/8
Phase 3
8%
1/12
Approved: 1Overall Success rate: 3%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Novartis
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use